Expert second opinions for left main coronary disease. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Left Main Coronary Disease isease involves significant narrowing of the artery that supplies approximately 75% of the heart's blood flow. If you are facing a decision about left main coronary disease, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Left main coronary artery disease involves significant narrowing of the artery that supplies approximately 75% of the heart's blood flow. Historically an indication for bypass surgery, it is now the subject of intense debate regarding the role of PCI in select cases.
Left main disease is too important for a single opinion. The EXCEL and NOBLE trials produced conflicting results about PCI vs CABG, making this decision highly nuanced. SYNTAX score, distal bifurcation involvement, calcification, and patient comorbidities all influence the optimal approach.
Surgery for left main coronary disease depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Left main disease is too important for a single opinion. The EXCEL and NOBLE trials produced conflicting results about PCI vs CABG, making this decision highly nuanced. SYNTAX score, distal bifurcation involvement, calcification, and patient comorbidities all influence the optimal approach.
Operative mortality for left main coronary disease-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for left main coronary disease depends on anatomy, comorbidities, age, and personal goals. CABG vs PCI for left main disease. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.